| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.67e-07 | 24 | 133 | 5 | GO:0099507 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 5.99e-07 | 11 | 133 | 4 | GO:0008503 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.86e-06 | 5 | 133 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 5.35e-06 | 18 | 133 | 4 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 6.75e-06 | 19 | 133 | 4 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.25e-05 | 22 | 133 | 4 | GO:0016917 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.86e-05 | 57 | 133 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.95e-05 | 60 | 133 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 7.29e-05 | 65 | 133 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 7.29e-05 | 65 | 133 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 RYR1 GABRA1 GABRA2 GABRA3 GABRA5 | 8.21e-05 | 334 | 133 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1B GRIN1 ITGA5 PKDREJ RYR1 CELSR1 CELSR3 VCAN EDEM2 DCHS1 PLA2G4F MMP12 BAIAP3 SLC25A23 PCDH18 | 1.42e-04 | 749 | 133 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.44e-04 | 75 | 133 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A CACNA1B SLC25A27 SLC38A5 GRIN1 KCNG3 KCNB2 PKDREJ RYR1 SLC45A1 SLC25A23 GABRA1 GABRA2 GABRA3 GABRA5 | 1.62e-04 | 758 | 133 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.64e-04 | 77 | 133 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | amide binding | 1.80e-04 | 299 | 133 | 9 | GO:0033218 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 PKDREJ RYR1 GABRA1 GABRA2 GABRA3 GABRA5 | 2.56e-04 | 459 | 133 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B SLC25A27 APOF SLC38A5 GRIN1 KCNG3 KCNB2 PKDREJ RYR1 CNNM3 SLC35E2A ABCC12 ATP11A SLC45A1 SLC25A23 GABRA1 GABRA2 GABRA3 GABRA5 | 3.41e-04 | 1289 | 133 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.42e-04 | 50 | 133 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 5.46e-04 | 152 | 133 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.52e-04 | 100 | 133 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 PKDREJ RYR1 GABRA1 GABRA2 GABRA3 GABRA5 | 7.87e-04 | 525 | 133 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 PKDREJ RYR1 GABRA1 GABRA2 GABRA3 GABRA5 | 7.99e-04 | 526 | 133 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B SLC25A27 SLC38A5 GRIN1 KCNG3 KCNB2 PKDREJ RYR1 SLC45A1 GABRA1 GABRA2 GABRA3 GABRA5 | 8.37e-04 | 793 | 133 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B SLC25A27 SLC38A5 GRIN1 KCNG3 KCNB2 PKDREJ RYR1 CNNM3 SLC35E2A ABCC12 SLC45A1 SLC25A23 GABRA1 GABRA2 GABRA3 GABRA5 | 8.43e-04 | 1180 | 133 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.01e-03 | 171 | 133 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.39e-03 | 182 | 133 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.47e-03 | 184 | 133 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.51e-03 | 125 | 133 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.54e-03 | 9 | 133 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.54e-03 | 9 | 133 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.73e-03 | 129 | 133 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.87e-03 | 193 | 133 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.08e-03 | 197 | 133 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.62e-03 | 86 | 133 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.43e-03 | 151 | 133 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.43e-03 | 151 | 133 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.56e-03 | 46 | 133 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.80e-03 | 14 | 133 | 2 | GO:0008331 | |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 CACNA1A LZTS3 FBF1 CNTNAP1 LAMA3 GRIN1 ITGA5 PIP5K1C ZDHHC8 LSR PKP3 AFDN MMP14 SDC4 GABRA1 GABRA2 GABRA3 GABRA5 | 3.99e-09 | 569 | 132 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 TANC2 CACNA1A LZTS3 FBF1 CNTNAP1 LAMA3 GRIN1 ITGA5 PIP5K1C ZDHHC8 LSR PKP3 CHRD AFDN TANC1 MMP14 SDC4 GABRA1 GABRA2 GABRA3 GABRA5 | 2.38e-07 | 974 | 132 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 2.77e-06 | 35 | 132 | 5 | GO:0007214 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 7.95e-06 | 74 | 132 | 6 | GO:0051932 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 MAG TANC2 CACNA1A ISLR2 LZTS3 SZT2 CNTNAP1 DVL3 LAMA3 GRIN1 PIP5K1C CELSR3 COBL AFDN TBR1 MYO16 | 1.46e-05 | 802 | 132 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 MAG TANC2 CACNA1A ISLR2 LZTS3 SZT2 CNTNAP1 DVL3 LAMA3 GRIN1 PIP5K1C CELSR3 COBL AFDN TBR1 MYO16 | 1.91e-05 | 819 | 132 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 MAG TANC2 CACNA1A ISLR2 LZTS3 SZT2 CNTNAP1 DVL3 LAMA3 GRIN1 PIP5K1C CELSR3 COBL AFDN TBR1 MYO16 | 2.13e-05 | 826 | 132 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB3 CACNA1A LZTS3 GRIN1 ZDHHC8 AFDN GABRA1 GABRA2 GABRA3 GABRA5 | 2.98e-05 | 308 | 132 | 10 | GO:0007416 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 3.86e-05 | 30 | 132 | 4 | GO:1904862 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 MAG TANC2 CACNA1A ONECUT2 RPGRIP1 ISLR2 SETX LZTS3 HLA-C SZT2 CNTNAP1 DVL3 LAMA3 GRIN1 PIP5K1C CELSR3 COBL AFDN TBR1 SDC4 MYO16 GABRA5 | 5.17e-05 | 1463 | 132 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 8.05e-05 | 36 | 132 | 4 | GO:0007274 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 MAG TANC2 CACNA1A ISLR2 LZTS3 SZT2 CNTNAP1 LAMA3 GRIN1 PIP5K1C CELSR3 COBL AFDN TBR1 | 9.01e-05 | 748 | 132 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1A CACNA1B DMXL2 APBA2 GRIN1 PIP5K1C SYDE1 RIMBP3 CHRD AFDN RIMBP3C RIMBP3B BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 9.44e-05 | 931 | 132 | 17 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1A CACNA1B DMXL2 APBA2 GRIN1 PIP5K1C SYDE1 RIMBP3 CHRD AFDN RIMBP3C RIMBP3B BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 9.44e-05 | 931 | 132 | 17 | GO:0007268 |
| GeneOntologyBiologicalProcess | dendritic spine organization | 9.75e-05 | 115 | 132 | 6 | GO:0097061 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1A CACNA1B DMXL2 APBA2 GRIN1 PIP5K1C SYDE1 RIMBP3 CHRD AFDN RIMBP3C RIMBP3B BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 1.05e-04 | 939 | 132 | 17 | GO:0099537 |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 TANC2 CACNA1A LZTS3 CNTNAP1 GRIN1 ZDHHC8 CHRD AFDN TANC1 GABRA1 GABRA2 GABRA3 GABRA5 | 1.29e-04 | 685 | 132 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1A CACNA1B DMXL2 APBA2 GRIN1 PIP5K1C SYDE1 RIMBP3 CHRD AFDN RIMBP3C RIMBP3B BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 1.66e-04 | 976 | 132 | 17 | GO:0099536 |
| GeneOntologyBiologicalProcess | neuron projection organization | 1.68e-04 | 127 | 132 | 6 | GO:0106027 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 MAG TANC2 CACNA1A ISLR2 SETX LZTS3 HLA-C SZT2 CNTNAP1 DVL3 LAMA3 GRIN1 PIP5K1C CELSR3 COBL AFDN TBR1 SDC4 MYO16 | 1.94e-04 | 1285 | 132 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 MAG TANC2 CACNA1A ISLR2 LZTS3 SZT2 CNTNAP1 DVL3 LAMA3 GRIN1 PIP5K1C SYNE3 CELSR3 PDZD8 COBL AFDN TBR1 MYO16 | 2.15e-04 | 1194 | 132 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB3 MAG CACNA1A DMXL2 SZT2 CNTNAP1 COQ8B DVL3 GRIN1 LSR CELSR1 UCHL5 VCAN CHRD AFDN TBR1 PCDH18 MYO16 MOG | 2.22e-04 | 1197 | 132 | 19 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | EPHB3 CACNA1A DMXL2 SCHIP1 SZT2 COQ8B DVL3 GRIN1 AXIN1 UCHL5 CHRD AFDN TBR1 MMP14 PCDH18 MYO16 | 2.63e-04 | 919 | 132 | 16 | GO:0060322 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB3 MAG CACNA1A ISLR2 SZT2 CNTNAP1 LAMA3 GRIN1 PIP5K1C CELSR3 COBL TBR1 | 2.85e-04 | 566 | 132 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of response to osmotic stress | 3.13e-04 | 21 | 132 | 3 | GO:0047484 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 4.25e-04 | 55 | 132 | 4 | GO:0060071 | |
| GeneOntologyCellularComponent | presynaptic active zone | CACNA1A CACNA1B VPS11 CNTNAP1 GRIN1 CELSR3 AFDN GABRA2 GABRA3 | 2.63e-07 | 141 | 131 | 9 | GO:0048786 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 5.31e-06 | 19 | 131 | 4 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 8.12e-06 | 21 | 131 | 4 | GO:1902710 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 9.58e-06 | 78 | 131 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | dendrite membrane | 2.65e-05 | 56 | 131 | 5 | GO:0032590 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.46e-05 | 210 | 131 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | apical junction complex | 6.29e-05 | 158 | 131 | 7 | GO:0043296 | |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1A GRIN1 PIP5K1C DENND1A CELSR3 AFDN GABRA2 GABRA3 GABRA5 | 6.39e-05 | 277 | 131 | 9 | GO:0042734 |
| GeneOntologyCellularComponent | presynapse | CACNA1A CACNA1B VPS11 DMXL2 CNTNAP1 APBA2 GRIN1 PIP5K1C DENND1A CELSR3 AFDN TANC1 BAIAP3 GABRA2 GABRA3 GABRA5 | 1.37e-04 | 886 | 131 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 RYR1 GABRA1 GABRA2 GABRA3 GABRA5 | 1.38e-04 | 378 | 131 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | neuron projection membrane | 1.66e-04 | 82 | 131 | 5 | GO:0032589 | |
| GeneOntologyCellularComponent | tight junction | 2.45e-04 | 139 | 131 | 6 | GO:0070160 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.79e-04 | 201 | 131 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A GRIN1 ITGA5 PIP5K1C DENND1A SYDE1 CELSR3 AFDN GABRA1 GABRA2 GABRA3 GABRA5 | 3.08e-04 | 583 | 131 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | cell leading edge | GRIN1 ITGA5 PIP5K1C TUBG1 ARAP3 COBL PLA2G4F GABRA1 GABRA2 GABRA3 GABRA5 | 3.16e-04 | 500 | 131 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | dendrite | EPHB3 TANC2 CACNA1A CACNA1B LZTS3 APBA2 GRIN1 KCNB2 DENND1A COBL TANC1 GABRA1 GABRA2 GABRA3 GABRA5 | 3.17e-04 | 858 | 131 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB3 TANC2 CACNA1A CACNA1B LZTS3 APBA2 GRIN1 KCNB2 DENND1A COBL TANC1 GABRA1 GABRA2 GABRA3 GABRA5 | 3.25e-04 | 860 | 131 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 LZTS3 GRIN1 PIP5K1C CELSR3 AFDN TANC1 GABRA1 GABRA2 GABRA3 GABRA5 | 3.32e-04 | 503 | 131 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | chloride channel complex | 4.50e-04 | 57 | 131 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 RYR1 ATP11A GABRA1 GABRA2 GABRA3 GABRA5 | 6.99e-04 | 550 | 131 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | manchette | 7.03e-04 | 28 | 131 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.04e-03 | 405 | 131 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | cell-cell junction | FBF1 CNTNAP1 LAMA3 MAGI3 PARD3B YBX3 ITGA5 PIP5K1C LSR PKP3 AFDN | 1.25e-03 | 591 | 131 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 RYR1 GABRA1 GABRA2 GABRA3 GABRA5 | 1.71e-03 | 523 | 131 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB3 TANC2 CACNA1A CACNA1B SLC25A27 LZTS3 APBA2 GRIN1 KCNB2 DENND1A COBL AFDN TANC1 GABRA1 GABRA2 GABRA3 GABRA5 | 1.74e-03 | 1228 | 131 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | postsynapse | TANC2 CACNA1A LZTS3 APBA2 GRIN1 ITGA5 PIP5K1C ZDHHC8 CELSR3 AFDN TANC1 GABRA1 GABRA2 GABRA3 GABRA5 | 1.80e-03 | 1018 | 131 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.00e-03 | 46 | 131 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | anchoring junction | FBF1 CNTNAP1 LAMA3 MAGI3 PARD3B YBX3 ITGA2B ITGA5 PIP5K1C LSR PKP3 AFDN MMP14 SDC4 | 3.26e-03 | 976 | 131 | 14 | GO:0070161 |
| MousePheno | abnormal GABA-mediated receptor currents | 8.81e-06 | 18 | 106 | 4 | MP:0004008 | |
| MousePheno | abnormal inhibitory postsynaptic currents | 1.46e-05 | 70 | 106 | 6 | MP:0002945 | |
| MousePheno | abnormal CNS synaptic transmission | MAG TANC2 CACNA1A CACNA1B SMCHD1 PRSS33 GRIN1 PIP5K1C ZDHHC8 SYDE1 SBF1 CHRD PDZD8 AFDN TBR1 BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 4.36e-05 | 985 | 106 | 20 | MP:0002206 |
| MousePheno | abnormal miniature inhibitory postsynaptic currents | 4.46e-05 | 52 | 106 | 5 | MP:0009435 | |
| MousePheno | abnormal behavioral response to xenobiotic | CACNA1A CACNA1B SZT2 GRIN1 TUBG1 RYR1 BAIAP3 GABRA1 GABRA2 GABRA5 | 1.18e-04 | 309 | 106 | 10 | MP:0009745 |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 1.36e-04 | 35 | 106 | 4 | MP:0004522 | |
| MousePheno | abnormal synaptic transmission | MAG TANC2 CACNA1A CACNA1B SMCHD1 PRSS33 GRIN1 PIP5K1C ZDHHC8 SYDE1 SBF1 CHRD PDZD8 AFDN TBR1 BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 1.37e-04 | 1070 | 106 | 20 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | MAG TANC2 CACNA1A CACNA1B SMCHD1 PRSS33 GRIN1 PIP5K1C ZDHHC8 SYDE1 SBF1 CHRD PDZD8 AFDN TBR1 BAIAP3 GABRA1 GABRA2 GABRA3 GABRA5 | 1.48e-04 | 1076 | 106 | 20 | MP:0021009 |
| Domain | GABAAa_rcpt | 3.22e-08 | 6 | 129 | 4 | IPR001390 | |
| Domain | Laminin_G | 2.91e-06 | 58 | 129 | 6 | IPR001791 | |
| Domain | Laminin_G_2 | 7.88e-06 | 40 | 129 | 5 | PF02210 | |
| Domain | LamG | 1.27e-05 | 44 | 129 | 5 | SM00282 | |
| Domain | - | EPHB3 EPHB4 MAG ISLR2 ADAMTSL1 COL12A1 VSIG2 HLA-C RIMBP3 MST1R LSR VCAN RIMBP3C RIMBP3B MOG ADGRA3 | 1.36e-05 | 663 | 129 | 16 | 2.60.40.10 |
| Domain | GABAA/Glycine_rcpt | 1.74e-05 | 23 | 129 | 4 | IPR006028 | |
| Domain | Ig-like_fold | EPHB3 EPHB4 MAG ISLR2 ADAMTSL1 COL12A1 VSIG2 HLA-C RIMBP3 MST1R LSR VCAN RIMBP3C RIMBP3B MOG ADGRA3 | 2.93e-05 | 706 | 129 | 16 | IPR013783 |
| Domain | Gamma_tubulin | 4.73e-05 | 2 | 129 | 2 | IPR002454 | |
| Domain | - | 5.08e-05 | 95 | 129 | 6 | 2.60.120.200 | |
| Domain | PDZ | 5.59e-05 | 141 | 129 | 7 | PF00595 | |
| Domain | PDZ | 7.59e-05 | 148 | 129 | 7 | SM00228 | |
| Domain | - | 8.26e-05 | 150 | 129 | 7 | 2.30.42.10 | |
| Domain | GPS | 8.58e-05 | 34 | 129 | 4 | SM00303 | |
| Domain | PDZ | 8.62e-05 | 151 | 129 | 7 | PS50106 | |
| Domain | PDZ | 8.98e-05 | 152 | 129 | 7 | IPR001478 | |
| Domain | GPS | 1.20e-04 | 37 | 129 | 4 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 1.34e-04 | 38 | 129 | 4 | PS50025 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.60e-04 | 45 | 129 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 2.83e-04 | 46 | 129 | 4 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 3.08e-04 | 47 | 129 | 4 | IPR006029 | |
| Domain | - | 3.08e-04 | 47 | 129 | 4 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 3.08e-04 | 47 | 129 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 3.08e-04 | 47 | 129 | 4 | PS00236 | |
| Domain | Neur_channel | 3.08e-04 | 47 | 129 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 3.08e-04 | 47 | 129 | 4 | IPR006202 | |
| Domain | ConA-like_dom | 8.26e-04 | 219 | 129 | 7 | IPR013320 | |
| Domain | HRM | 9.29e-04 | 28 | 129 | 3 | PF02793 | |
| Domain | Ca_chan_IQ | 9.72e-04 | 7 | 129 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 9.72e-04 | 7 | 129 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 9.72e-04 | 7 | 129 | 2 | IPR014873 | |
| Domain | GPHH | 9.72e-04 | 7 | 129 | 2 | PF16905 | |
| Domain | DIX | 9.72e-04 | 7 | 129 | 2 | PF00778 | |
| Domain | GPHH_dom | 9.72e-04 | 7 | 129 | 2 | IPR031649 | |
| Domain | DIX | 9.72e-04 | 7 | 129 | 2 | IPR001158 | |
| Domain | DIX | 9.72e-04 | 7 | 129 | 2 | PS50841 | |
| Domain | DAX | 9.72e-04 | 7 | 129 | 2 | SM00021 | |
| Domain | EGF_LAM_2 | 1.14e-03 | 30 | 129 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.14e-03 | 30 | 129 | 3 | PS01248 | |
| Domain | Ion_trans_dom | 1.17e-03 | 114 | 129 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.17e-03 | 114 | 129 | 5 | PF00520 | |
| Domain | EGF_Lam | 1.79e-03 | 35 | 129 | 3 | SM00180 | |
| Domain | GPS | 1.79e-03 | 35 | 129 | 3 | PF01825 | |
| Domain | Laminin_EGF | 1.79e-03 | 35 | 129 | 3 | PF00053 | |
| Domain | GPS | 1.95e-03 | 36 | 129 | 3 | PS50221 | |
| Domain | VDCCAlpha1 | 2.05e-03 | 10 | 129 | 2 | IPR002077 | |
| Domain | Laminin_EGF | 2.28e-03 | 38 | 129 | 3 | IPR002049 | |
| Domain | Ephrin_rec_like | 2.50e-03 | 11 | 129 | 2 | PF07699 | |
| Domain | GAIN_dom_N | 2.50e-03 | 11 | 129 | 2 | IPR032471 | |
| Domain | Integrin_alpha | 2.50e-03 | 11 | 129 | 2 | PF00357 | |
| Domain | GAIN | 2.50e-03 | 11 | 129 | 2 | PF16489 | |
| Domain | FN3 | 2.61e-03 | 199 | 129 | 6 | PS50853 | |
| Domain | GPCR_2_extracellular_dom | 2.64e-03 | 40 | 129 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.64e-03 | 40 | 129 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.64e-03 | 40 | 129 | 3 | PS50227 | |
| Domain | FN3_dom | 3.33e-03 | 209 | 129 | 6 | IPR003961 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.08e-03 | 14 | 129 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.08e-03 | 14 | 129 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.08e-03 | 14 | 129 | 2 | IPR001426 | |
| Domain | EphA2_TM | 4.08e-03 | 14 | 129 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.08e-03 | 14 | 129 | 2 | IPR001090 | |
| Domain | Eph_TM | 4.08e-03 | 14 | 129 | 2 | IPR027936 | |
| Domain | EPH_lbd | 4.08e-03 | 14 | 129 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 4.08e-03 | 14 | 129 | 2 | PF01404 | |
| Domain | uDENN | 4.08e-03 | 14 | 129 | 2 | SM00800 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.08e-03 | 14 | 129 | 2 | IPR016257 | |
| Domain | EPH_LBD | 4.08e-03 | 14 | 129 | 2 | PS51550 | |
| Domain | Neurexin-like | 4.08e-03 | 14 | 129 | 2 | IPR003585 | |
| Domain | 4.1m | 4.08e-03 | 14 | 129 | 2 | SM00294 | |
| Domain | uDENN | 4.69e-03 | 15 | 129 | 2 | PF03456 | |
| Domain | Pept_M10A_Zn_BS | 4.69e-03 | 15 | 129 | 2 | IPR021158 | |
| Domain | 7tm_2 | 4.98e-03 | 50 | 129 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.98e-03 | 50 | 129 | 3 | PS00650 | |
| Domain | DENN | 5.33e-03 | 16 | 129 | 2 | SM00799 | |
| Domain | DENN | 5.33e-03 | 16 | 129 | 2 | PF02141 | |
| Domain | dDENN | 5.33e-03 | 16 | 129 | 2 | PF03455 | |
| Domain | UDENN | 5.33e-03 | 16 | 129 | 2 | PS50946 | |
| Domain | DDENN | 5.33e-03 | 16 | 129 | 2 | PS50947 | |
| Domain | Integrin_alpha_C_CS | 5.33e-03 | 16 | 129 | 2 | IPR018184 | |
| Domain | dDENN | 5.33e-03 | 16 | 129 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.33e-03 | 16 | 129 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.33e-03 | 16 | 129 | 2 | IPR005113 | |
| Domain | DENN | 5.33e-03 | 16 | 129 | 2 | PS50211 | |
| Domain | DENN_dom | 5.33e-03 | 16 | 129 | 2 | IPR001194 | |
| Domain | BTB_2 | 5.86e-03 | 53 | 129 | 3 | PF02214 | |
| Domain | T1-type_BTB | 5.86e-03 | 53 | 129 | 3 | IPR003131 | |
| Domain | Hemopexin_CS | 6.02e-03 | 17 | 129 | 2 | IPR018486 | |
| Domain | Integrin_alpha-2 | 6.74e-03 | 18 | 129 | 2 | IPR013649 | |
| Domain | Pept_M10A_stromelysin-type | 6.74e-03 | 18 | 129 | 2 | IPR016293 | |
| Domain | INTEGRIN_ALPHA | 6.74e-03 | 18 | 129 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 6.74e-03 | 18 | 129 | 2 | PF08441 | |
| Domain | Integrin_alpha | 6.74e-03 | 18 | 129 | 2 | IPR000413 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 3.07e-09 | 10 | 95 | 5 | MM1401 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 2.38e-07 | 9 | 95 | 4 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 3.94e-07 | 10 | 95 | 4 | M477 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.70e-05 | 11 | 95 | 3 | M47958 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 5.30e-05 | 31 | 95 | 4 | M39369 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.20e-04 | 38 | 95 | 4 | M39854 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.31e-04 | 73 | 95 | 5 | MM16641 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.88e-04 | 300 | 95 | 9 | M610 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.54e-04 | 84 | 95 | 5 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.48e-04 | 258 | 95 | 8 | MM14572 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA1A CACNA1B GRIN1 KCNG3 KCNB2 GABRA1 GABRA2 GABRA3 GABRA5 | 4.24e-04 | 335 | 95 | 9 | MM14503 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.40e-04 | 53 | 95 | 4 | MM14566 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CACNA1A CACNA1B APBA2 GRIN1 KCNG3 KCNB2 GABRA1 GABRA2 GABRA3 GABRA5 | 4.41e-04 | 411 | 95 | 10 | M735 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.53e-04 | 211 | 95 | 7 | MM14502 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 7.07e-04 | 60 | 95 | 4 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 7.07e-04 | 60 | 95 | 4 | M976 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 9.03e-04 | 64 | 95 | 4 | M26953 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 TANC2 TPRA1 SZT2 KTI12 ITGA5 ARHGEF11 PIP5K1C ZDHHC8 DENND1A TUBG1 RYR1 MST1R CELSR1 SYNE3 ARAP3 CELSR3 SBF1 PDZD8 COBL TANC1 SLC45A1 MMP14 CEP170B | 5.38e-12 | 1105 | 133 | 24 | 35748872 |
| Pubmed | 2.04e-10 | 4 | 133 | 4 | 25865415 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 1.02e-09 | 5 | 133 | 4 | 30104684 | |
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 3.05e-09 | 6 | 133 | 4 | 15033447 | |
| Pubmed | 3.05e-09 | 6 | 133 | 4 | 20457185 | ||
| Pubmed | LZTS3 MAGI3 GRIN1 KCNB2 ZDHHC8 AFDN TANC1 GABRA1 GABRA2 GABRA3 | 4.99e-09 | 197 | 133 | 10 | 36604605 | |
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 7.09e-09 | 7 | 133 | 4 | 20843900 | |
| Pubmed | 7.09e-09 | 7 | 133 | 4 | 35228700 | ||
| Pubmed | 1.90e-08 | 22 | 133 | 5 | 35245678 | ||
| Pubmed | 4.22e-08 | 10 | 133 | 4 | 36733270 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 15017002 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 16835366 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 15304513 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 1356407 | ||
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 6.61e-08 | 11 | 133 | 4 | 25024228 | |
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 6.61e-08 | 11 | 133 | 4 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 6.61e-08 | 11 | 133 | 4 | 38894703 | |
| Pubmed | 1.42e-07 | 13 | 133 | 4 | 22569571 | ||
| Pubmed | 1.42e-07 | 13 | 133 | 4 | 22640814 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 26518133 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 25080596 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 31253182 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.18e-07 | 4 | 133 | 3 | 19091768 | |
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 2.18e-07 | 4 | 133 | 3 | 20692323 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 2.18e-07 | 4 | 133 | 3 | 18821008 | |
| Pubmed | A two-kinesin mechanism controls neurogenesis in the developing brain. | 5.44e-07 | 5 | 133 | 3 | 38040957 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 5.44e-07 | 5 | 133 | 3 | 17855024 | |
| Pubmed | 6.00e-07 | 18 | 133 | 4 | 19078961 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 21751815 | ||
| Pubmed | 1.16e-06 | 21 | 133 | 4 | 25708312 | ||
| Pubmed | TANC2 CACNA1A CACNA1B DMXL2 ACACB LZTS3 CNTNAP1 DVL3 APBA2 GRIN1 KCNB2 TUBG1 AFDN CEP170B GABRA1 GABRA2 GABRA5 | 1.77e-06 | 1139 | 133 | 17 | 36417873 | |
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 7560270 | ||
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 38827526 | ||
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 17021187 | ||
| Pubmed | 1.89e-06 | 7 | 133 | 3 | 16101898 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 18490449 | ||
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 8175718 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 3.02e-06 | 8 | 133 | 3 | 18185516 | |
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 11528422 | ||
| Pubmed | 3.45e-06 | 164 | 133 | 7 | 32409323 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 6.05e-06 | 67 | 133 | 5 | 21875946 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 6.05e-06 | 67 | 133 | 5 | 16987237 | |
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 6.43e-06 | 10 | 133 | 3 | 21789198 | |
| Pubmed | 6.43e-06 | 10 | 133 | 3 | 20592197 | ||
| Pubmed | A role for primary cilia in aortic valve development and disease. | 6.43e-06 | 10 | 133 | 3 | 28556366 | |
| Pubmed | 6.76e-06 | 32 | 133 | 4 | 23154389 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 6.84e-06 | 182 | 133 | 7 | 20468064 | |
| Pubmed | TANC2 CACNA1A CACNA1B DMXL2 CNTNAP1 GRIN1 CEP170B GABRA1 GABRA3 | 8.12e-06 | 347 | 133 | 9 | 17114649 | |
| Pubmed | 8.82e-06 | 11 | 133 | 3 | 34274973 | ||
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 1.17e-05 | 12 | 133 | 3 | 2561974 | |
| Pubmed | DMXL2 COL12A1 LZTS3 COQ8B SYDE1 TUBG1 LSR SYNE3 SBF1 RIMBP3C TBR1 ZNF646 | 1.44e-05 | 689 | 133 | 12 | 36543142 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11378843 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22763624 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.45e-05 | 2 | 133 | 2 | 23426690 | |
| Pubmed | EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. | 1.45e-05 | 2 | 133 | 2 | 11136979 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23147414 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29477585 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23109109 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22666188 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 27155990 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 7478528 | ||
| Pubmed | MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages. | 1.45e-05 | 2 | 133 | 2 | 17442887 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23376566 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 8391122 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22806905 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 18973555 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31056671 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 38155373 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 1.45e-05 | 2 | 133 | 2 | 18202657 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 36469977 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26446222 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17287496 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 9655866 | ||
| Pubmed | Plakophilin 3 mediates Rap1-dependent desmosome assembly and adherens junction maturation. | 1.45e-05 | 2 | 133 | 2 | 25208567 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28119396 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 1.45e-05 | 2 | 133 | 2 | 11021797 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19457072 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 18085262 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24553732 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21073549 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23373994 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23744069 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 1.45e-05 | 2 | 133 | 2 | 15341600 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21056629 | ||
| Pubmed | Axin localizes to the centrosome and is involved in microtubule nucleation. | 1.45e-05 | 2 | 133 | 2 | 19390532 | |
| Pubmed | UCHL5 controls β-catenin destruction complex function through Axin1 regulation. | 1.45e-05 | 2 | 133 | 2 | 35256667 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 18328539 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16253225 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23067879 | ||
| Pubmed | Gene knockout analysis of two gamma-tubulin isoforms in mice. | 1.45e-05 | 2 | 133 | 2 | 15893303 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 15050706 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21068316 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 1.45e-05 | 2 | 133 | 2 | 26973458 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34517516 | ||
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 23830831 | ||
| Pubmed | 1.54e-05 | 81 | 133 | 5 | 22723691 | ||
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 1.93e-05 | 14 | 133 | 3 | 17662146 | |
| Pubmed | 1.93e-05 | 14 | 133 | 3 | 24381198 | ||
| Pubmed | 1.93e-05 | 14 | 133 | 3 | 22768092 | ||
| Interaction | GABRA5 interactions | 2.66e-06 | 5 | 131 | 3 | int:GABRA5 | |
| Interaction | TOP3B interactions | EPHB4 TANC2 TPRA1 SZT2 PLEKHA4 KTI12 ITGA5 ARHGEF11 PIP5K1C ZDHHC8 DENND1A TUBG1 RYR1 MST1R CELSR1 SYNE3 ARAP3 CELSR3 SBF1 PDZD8 COBL TANC1 SLC45A1 MMP14 CEP170B | 7.81e-06 | 1470 | 131 | 25 | int:TOP3B |
| Interaction | RHOF interactions | EPHB4 TANC2 HLA-C COQ8B SLC38A5 KTI12 ITGA5 PIP5K1C ZDHHC8 SYDE1 CNNM3 LSR SBF1 COBL ATP11A TANC1 | 7.83e-06 | 673 | 131 | 16 | int:RHOF |
| Interaction | BTNL2 interactions | 7.94e-06 | 155 | 131 | 8 | int:BTNL2 | |
| Interaction | RYK interactions | 1.04e-05 | 212 | 131 | 9 | int:RYK | |
| Interaction | NCR3 interactions | 1.35e-05 | 120 | 131 | 7 | int:NCR3 | |
| Interaction | RHOJ interactions | EPHB4 HLA-C DVL3 SLC38A5 ITGA5 PIP5K1C ZDHHC8 SYDE1 CNNM3 LSR SBF1 PDZD8 COBL ATP11A TANC1 | 1.60e-05 | 633 | 131 | 15 | int:RHOJ |
| Interaction | SIPA1L1 interactions | 1.84e-05 | 174 | 131 | 8 | int:SIPA1L1 | |
| Interaction | GABRA3 interactions | 3.09e-05 | 28 | 131 | 4 | int:GABRA3 | |
| Interaction | RAC3 interactions | EPHB4 HLA-C PLEKHA4 SLC38A5 ITGA5 ZDHHC8 SYDE1 CNNM3 LSR ARAP3 SBF1 PDZD8 ATP11A TANC1 | 5.16e-05 | 619 | 131 | 14 | int:RAC3 |
| Interaction | EPHB3 interactions | 7.64e-05 | 35 | 131 | 4 | int:EPHB3 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.08e-06 | 19 | 99 | 4 | 563 | |
| GeneFamily | PDZ domain containing | 2.02e-05 | 152 | 99 | 7 | 1220 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 8.87e-05 | 3 | 99 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 8.87e-05 | 3 | 99 | 2 | 1189 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.81e-04 | 181 | 99 | 6 | 694 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.08e-03 | 37 | 99 | 3 | 763 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.59e-03 | 14 | 99 | 2 | 1095 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.29e-03 | 18 | 99 | 2 | 1160 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | EPHB3 CACNA1A CACNA1B ONECUT2 SLC25A27 HIC1 COL12A1 FOXQ1 HLA-C PARD3B GRIN1 RIMBP3 MKX CHRD RIMBP3C TBR1 RIMBP3B LRRC71 GABRA2 | 3.29e-06 | 1115 | 132 | 19 | M10371 |
| Coexpression | BENPORATH_EED_TARGETS | EPHB3 CACNA1B ONECUT2 HIC1 COL12A1 FOXQ1 VSIG2 HLA-C RIMBP3 EDEM2 MKX CHRD RIMBP3C TBR1 RIMBP3B LRRC71 GABRA2 | 2.43e-05 | 1059 | 132 | 17 | M7617 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 2.63e-05 | 235 | 132 | 8 | M2256 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ONECUT2 HIC1 COL12A1 FOXQ1 SCRT1 ITGA5 KCNG3 KCTD11 PKDREJ SYNE3 MKX CHRD TBR1 MMP14 CHST7 SDC4 MYO16 | 2.90e-05 | 1074 | 132 | 17 | M1941 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | SCHIP1 ZNF219 COL12A1 PLEKHA4 LAMA3 SLC38A5 SYDE1 VCAN DCHS1 CHST7 PCDH18 | 3.22e-05 | 479 | 132 | 11 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | SCHIP1 ZNF219 COL12A1 PLEKHA4 LAMA3 SLC38A5 SYDE1 VCAN DCHS1 CHST7 PCDH18 | 3.47e-05 | 483 | 132 | 11 | MM1082 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | MAG DMXL2 COL11A2 MYO1H APBA2 ITGA2B ITGA5 RYR1 CES2 CELSR1 DCHS1 COBL HAS1 SLC25A23 GABRA2 | 4.90e-05 | 899 | 132 | 15 | M2242 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN | 5.67e-05 | 132 | 132 | 6 | M6764 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 7.15e-05 | 200 | 132 | 7 | M6636 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | MAG DMXL2 COL11A2 MYO1H APBA2 ITGA2B ITGA5 RYR1 CES2 CELSR1 DCHS1 COBL HAS1 SLC25A23 GABRA2 | 7.17e-05 | 930 | 132 | 15 | MM893 |
| CoexpressionAtlas | cerebral cortex | MAG CACNA1A CACNA1B ISLR2 SCHIP1 LARP6 SCRT1 LZTS3 CNTNAP1 APBA2 GRIN1 KCNG3 KCNB2 CELSR3 AK5 GAL3ST3 SLC45A1 TBR1 BAIAP3 MYO16 GABRA1 GABRA2 GABRA3 GABRA5 | 4.74e-06 | 1428 | 129 | 24 | cerebral cortex |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CACNA1B HIC1 SETX FOXQ1 SZT2 LAMA3 MSL1 TMEM132C CELSR1 AK5 VCAN MKX PCDH18 GABRA1 GABRA3 ZNF646 | 3.11e-05 | 806 | 129 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.05e-10 | 200 | 133 | 10 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.58e-09 | 188 | 133 | 9 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.51e-08 | 184 | 133 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.51e-08 | 184 | 133 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 9.64e-08 | 187 | 133 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.61e-07 | 200 | 133 | 8 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 148 | 133 | 7 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 148 | 133 | 7 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 148 | 133 | 7 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-07 | 170 | 133 | 7 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 8.10e-07 | 170 | 133 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-07 | 170 | 133 | 7 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 9.47e-07 | 174 | 133 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.10e-06 | 178 | 133 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 182 | 133 | 7 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.48e-06 | 186 | 133 | 7 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 192 | 133 | 7 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 192 | 133 | 7 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.83e-06 | 192 | 133 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 192 | 133 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.96e-06 | 194 | 133 | 7 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.02e-06 | 195 | 133 | 7 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 199 | 133 | 7 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 199 | 133 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.39e-06 | 200 | 133 | 7 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 2.39e-06 | 200 | 133 | 7 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.38e-06 | 142 | 133 | 6 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-06 | 151 | 133 | 6 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-06 | 162 | 133 | 6 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 165 | 133 | 6 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 165 | 133 | 6 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 170 | 133 | 6 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-05 | 172 | 133 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-05 | 175 | 133 | 6 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-05 | 175 | 133 | 6 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 176 | 133 | 6 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 177 | 133 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 178 | 133 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 179 | 133 | 6 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-05 | 181 | 133 | 6 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-05 | 184 | 133 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.92e-05 | 184 | 133 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.98e-05 | 185 | 133 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.98e-05 | 185 | 133 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.98e-05 | 185 | 133 | 6 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-05 | 185 | 133 | 6 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-05 | 186 | 133 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-05 | 186 | 133 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.11e-05 | 187 | 133 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-05 | 187 | 133 | 6 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-05 | 187 | 133 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-05 | 188 | 133 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 133 | 6 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 190 | 133 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.30e-05 | 190 | 133 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.37e-05 | 191 | 133 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 192 | 133 | 6 | f51b3fd962263920a6cae783ca7af13f5eb7aaa3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 193 | 133 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 193 | 133 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 193 | 133 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-05 | 193 | 133 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 193 | 133 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-05 | 194 | 133 | 6 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 194 | 133 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.59e-05 | 194 | 133 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-05 | 194 | 133 | 6 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 194 | 133 | 6 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 194 | 133 | 6 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | 11.5-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.67e-05 | 195 | 133 | 6 | 8cbc78a6cb812f907c69b00f85263976216840ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 195 | 133 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.67e-05 | 195 | 133 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.74e-05 | 196 | 133 | 6 | b74dbdfc8d9b85d7cae5c6a49b56347b15ce16e1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-05 | 196 | 133 | 6 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | distal-1-Epithelial-Alveolar_Epithelial_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-05 | 197 | 133 | 6 | d44b7dc7c6416ed9466889374c3ae39f43ac8bb6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 197 | 133 | 6 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 197 | 133 | 6 | b7aff83c27606d87565382a768119a863fe1c294 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 197 | 133 | 6 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 197 | 133 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.82e-05 | 197 | 133 | 6 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | wk_15-18-Epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 198 | 133 | 6 | 12bbe77c3d68bf1e545949dbb1eb49ed3641de3d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | 8d9858dcb21f20d0c040b22a2cae543eaebd54bc | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 199 | 133 | 6 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 199 | 133 | 6 | af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.99e-05 | 199 | 133 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-05 | 199 | 133 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.07e-05 | 200 | 133 | 6 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| Computational | Ion channels. | 1.26e-05 | 70 | 80 | 6 | MODULE_316 | |
| Computational | Genes in the cancer module 141. | 2.07e-04 | 16 | 80 | 3 | MODULE_141 | |
| Drug | Flumazenil | 1.01e-09 | 4 | 130 | 4 | DB01205 | |
| Drug | Eszopiclone | 5.05e-09 | 5 | 130 | 4 | DB00402 | |
| Drug | Zopiclone | 5.05e-09 | 5 | 130 | 4 | DB01198 | |
| Drug | Meprobamate | 1.51e-08 | 6 | 130 | 4 | DB00371 | |
| Drug | Quazepam | 3.50e-08 | 7 | 130 | 4 | DB01589 | |
| Drug | Adinazolam | 6.98e-08 | 8 | 130 | 4 | DB00546 | |
| Drug | Fludiazepam | 6.98e-08 | 8 | 130 | 4 | DB01567 | |
| Drug | Clotiazepam | 6.98e-08 | 8 | 130 | 4 | DB01559 | |
| Drug | Cinolazepam | 6.98e-08 | 8 | 130 | 4 | DB01594 | |
| Drug | Prazepam | 6.98e-08 | 8 | 130 | 4 | DB01588 | |
| Drug | Estazolam | 6.98e-08 | 8 | 130 | 4 | DB01215 | |
| Drug | Halazepam | 6.98e-08 | 8 | 130 | 4 | DB00801 | |
| Drug | Ethchlorvynol | 1.25e-07 | 9 | 130 | 4 | DB00189 | |
| Drug | Diazepam | 1.25e-07 | 9 | 130 | 4 | DB00829 | |
| Drug | Zolpidem | 1.82e-07 | 3 | 130 | 3 | DB00425 | |
| Drug | Secobarbital | 2.08e-07 | 10 | 130 | 4 | DB00418 | |
| Drug | Chlordiazepoxide | 2.08e-07 | 10 | 130 | 4 | DB00475 | |
| Drug | Metharbital | 2.08e-07 | 10 | 130 | 4 | DB00463 | |
| Drug | Pentobarbital | 2.08e-07 | 10 | 130 | 4 | DB00312 | |
| Drug | Talbutal | 2.08e-07 | 10 | 130 | 4 | DB00306 | |
| Drug | Clobazam | 2.08e-07 | 10 | 130 | 4 | DB00349 | |
| Drug | Butalbital | 2.08e-07 | 10 | 130 | 4 | DB00241 | |
| Drug | Butabarbital | 2.08e-07 | 10 | 130 | 4 | DB00237 | |
| Drug | Bromazepam | 2.08e-07 | 10 | 130 | 4 | DB01558 | |
| Drug | Barbituric acid derivative | 2.08e-07 | 10 | 130 | 4 | DB01496 | |
| Drug | Barbital | 2.08e-07 | 10 | 130 | 4 | DB01483 | |
| Drug | Hexobarbital | 2.08e-07 | 10 | 130 | 4 | DB01355 | |
| Drug | Aprobarbital | 2.08e-07 | 10 | 130 | 4 | DB01352 | |
| Drug | Amobarbital | 2.08e-07 | 10 | 130 | 4 | DB01351 | |
| Drug | Heptabarbital | 2.08e-07 | 10 | 130 | 4 | DB01354 | |
| Drug | Butethal | 2.08e-07 | 10 | 130 | 4 | DB01353 | |
| Drug | Methylphenobarbital | 2.08e-07 | 10 | 130 | 4 | DB00849 | |
| Drug | Oxazepam | 2.08e-07 | 10 | 130 | 4 | DB00842 | |
| Drug | Primidone | 2.08e-07 | 10 | 130 | 4 | DB00794 | |
| Drug | Midazolam | 2.08e-07 | 10 | 130 | 4 | DB00683 | |
| Drug | Flurazepam | 2.08e-07 | 10 | 130 | 4 | DB00690 | |
| Drug | Clonazepam | 2.08e-07 | 10 | 130 | 4 | DB01068 | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | EPHB3 ONECUT2 DMXL2 ZNF219 GRIN1 SYDE1 MST1R CELSR3 PKP3 BAIAP3 | 2.33e-07 | 200 | 130 | 10 | 6150_UP |
| Drug | thymol | 2.40e-07 | 46 | 130 | 6 | CID000006989 | |
| Drug | Thiopental | 3.25e-07 | 11 | 130 | 4 | DB00599 | |
| Drug | Alprazolam | 3.25e-07 | 11 | 130 | 4 | DB00404 | |
| Drug | Temazepam | 3.25e-07 | 11 | 130 | 4 | DB00231 | |
| Drug | Nitrazepam | 3.25e-07 | 11 | 130 | 4 | DB01595 | |
| Drug | Lorazepam | 3.25e-07 | 11 | 130 | 4 | DB00186 | |
| Drug | Phenobarbital | 3.25e-07 | 11 | 130 | 4 | DB01174 | |
| Drug | Triazolam | 3.25e-07 | 11 | 130 | 4 | DB00897 | |
| Drug | Clorazepate | 3.25e-07 | 11 | 130 | 4 | DB00628 | |
| Drug | etizolam | 7.25e-07 | 4 | 130 | 3 | ctd:C044610 | |
| Drug | 3-aminopropylphosphinic acid | 9.99e-07 | 32 | 130 | 5 | CID006335948 | |
| Drug | flurazepam | 1.59e-06 | 35 | 130 | 5 | CID000003393 | |
| Drug | beta-carboline | 1.76e-06 | 64 | 130 | 6 | CID000064961 | |
| Drug | Lorazepam | 1.80e-06 | 5 | 130 | 3 | ctd:D008140 | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A | 1.86e-06 | 195 | 130 | 9 | 2924_UP | |
| Drug | dihydroxyaflavinine | 2.28e-06 | 17 | 130 | 4 | CID000156857 | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; HL60; HT_HG-U133A | 2.29e-06 | 200 | 130 | 9 | 3111_UP | |
| Drug | procaine | 2.81e-06 | 153 | 130 | 8 | CID000004914 | |
| Drug | Flunitrazepam | 3.59e-06 | 6 | 130 | 3 | DB01544 | |
| Drug | vigabatrin | 8.76e-06 | 49 | 130 | 5 | CID000005665 | |
| Drug | gamma-acetylenic GABA | 9.87e-06 | 24 | 130 | 4 | CID000003452 | |
| Drug | methohexital | 9.87e-06 | 24 | 130 | 4 | CID000009034 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 9.98e-06 | 8 | 130 | 3 | ctd:C091518 | |
| Drug | colchine | COL11A2 COL12A1 LAMA3 TUBG1 ACTL7B VCAN SDC4 GABRA1 GABRA2 GABRA3 GABRA5 | 1.29e-05 | 383 | 130 | 11 | CID000002833 |
| Drug | tiotidine | 1.49e-05 | 9 | 130 | 3 | ctd:C023990 | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.55e-05 | 193 | 130 | 8 | 3197_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 4576_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; HL60; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 3059_DN | |
| Drug | AC1L1FKW | 2.12e-05 | 10 | 130 | 3 | CID000003281 | |
| Drug | clobazam | 2.16e-05 | 29 | 130 | 4 | CID000002789 | |
| Drug | 3-isothujone | 2.48e-05 | 30 | 130 | 4 | CID000011027 | |
| Drug | chondroitin sulfate | MAG COL11A2 COL12A1 NDST2 LAMA3 PIP5K1C VCAN HAS1 CHST7 SDC4 MOG | 2.58e-05 | 413 | 130 | 11 | CID000024766 |
| Drug | fosazepam | 2.90e-05 | 11 | 130 | 3 | CID000037114 | |
| Drug | C19H18ClN3O | 2.90e-05 | 11 | 130 | 3 | CID000027452 | |
| Drug | flutoprazepam | 2.90e-05 | 11 | 130 | 3 | CID000003400 | |
| Drug | Arfendazam | 2.90e-05 | 11 | 130 | 3 | CID000065803 | |
| Drug | camazepam | 2.90e-05 | 11 | 130 | 3 | CID000037367 | |
| Drug | Bu-1014 | 2.90e-05 | 11 | 130 | 3 | CID015942721 | |
| Drug | Zapizolam | 2.90e-05 | 11 | 130 | 3 | CID000068832 | |
| Drug | Reclazepam | 2.90e-05 | 11 | 130 | 3 | CID003052777 | |
| Drug | iclazepam | 2.90e-05 | 11 | 130 | 3 | CID000068777 | |
| Drug | menitrazepam | 2.90e-05 | 11 | 130 | 3 | CID000189875 | |
| Drug | Serin hydrazid | 2.90e-05 | 11 | 130 | 3 | CID000041637 | |
| Drug | sulazepam | 2.90e-05 | 11 | 130 | 3 | CID000017931 | |
| Drug | elfazepam | 2.90e-05 | 11 | 130 | 3 | CID000065445 | |
| Drug | triflubazam | 2.90e-05 | 11 | 130 | 3 | CID000031157 | |
| Drug | uldazepam | 2.90e-05 | 11 | 130 | 3 | CID000034274 | |
| Drug | gidazepam | 2.90e-05 | 11 | 130 | 3 | CID000121919 | |
| Drug | fletazepam | 2.90e-05 | 11 | 130 | 3 | CID000036834 | |
| Drug | CGS 8216 | 3.65e-05 | 33 | 130 | 4 | CID000104916 | |
| Drug | AC1L2FYN | 3.65e-05 | 33 | 130 | 4 | CID000071333 | |
| Drug | SB-205384 | 3.85e-05 | 12 | 130 | 3 | CID000197690 | |
| Drug | U-93631 | 3.85e-05 | 12 | 130 | 3 | CID000197626 | |
| Drug | haloxazolam | 3.85e-05 | 12 | 130 | 3 | CID000003563 | |
| Drug | doxefazepam | 3.85e-05 | 12 | 130 | 3 | CID000038668 | |
| Drug | pivoxazepam | 3.85e-05 | 12 | 130 | 3 | CID000068722 | |
| Drug | razobazam | 3.85e-05 | 12 | 130 | 3 | CID000071228 | |
| Drug | amobarbital | 4.12e-05 | 34 | 130 | 4 | CID000002163 | |
| Drug | nerisopam | 4.99e-05 | 13 | 130 | 3 | CID000065875 | |
| Drug | flutazolam | 4.99e-05 | 13 | 130 | 3 | CID000003398 | |
| Drug | 4-PIOL | 4.99e-05 | 13 | 130 | 3 | CID000125520 | |
| Drug | AC1MVFYM | 4.99e-05 | 13 | 130 | 3 | CID003707225 | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 1.81e-05 | 2 | 126 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.08e-04 | 4 | 126 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Marfan syndrome (is_marker_for) | 1.08e-04 | 4 | 126 | 2 | DOID:14323 (is_marker_for) | |
| Disease | Epileptic encephalopathy | 2.84e-04 | 30 | 126 | 3 | C0543888 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 3.75e-04 | 7 | 126 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Schizophrenia | MAG CACNA1B SLC25A27 HLA-C APBA2 ARHGEF11 ZDHHC8 EDEM2 MYO16 MOG GABRA1 GABRA5 | 4.12e-04 | 883 | 126 | 12 | C0036341 |
| Disease | Drug toxicity | 4.70e-04 | 84 | 126 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 4.70e-04 | 84 | 126 | 4 | C0041755 | |
| Disease | Developmental delay (disorder) | 5.31e-04 | 37 | 126 | 3 | C0424605 | |
| Disease | Erythema nodosum | 6.39e-04 | 9 | 126 | 2 | HP_0012219 | |
| Disease | asthma, response to diisocyanate | 9.19e-04 | 261 | 126 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 9.70e-04 | 11 | 126 | 2 | EFO_0009923 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 9.70e-04 | 11 | 126 | 2 | C1335302 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.21e-03 | 49 | 126 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | putamen volume change measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0021495 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 1.59e-03 | 14 | 126 | 2 | DOID:14004 (is_marker_for) | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 1.59e-03 | 14 | 126 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Arthritis, Psoriatic | 1.59e-03 | 14 | 126 | 2 | C0003872 | |
| Disease | Tremor, Rubral | 2.09e-03 | 16 | 126 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.09e-03 | 16 | 126 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.09e-03 | 16 | 126 | 2 | C0278161 | |
| Disease | alcohol use disorder (is_implicated_in) | 2.09e-03 | 16 | 126 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | 2-hydroxyglutarate measurement | 2.09e-03 | 16 | 126 | 2 | EFO_0021506 | |
| Disease | Ataxia, Sensory | 2.09e-03 | 16 | 126 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.09e-03 | 16 | 126 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 2.09e-03 | 16 | 126 | 2 | C0427190 | |
| Disease | alcohol consumption measurement | CACNA1A ONECUT2 COL12A1 ACACB MTERF1 MAGI3 KCNG3 DENND1A MST1R AK5 CDADC1 COBL GABRA2 | 2.56e-03 | 1242 | 126 | 13 | EFO_0007878 |
| Disease | Global developmental delay | 2.58e-03 | 133 | 126 | 4 | C0557874 | |
| Disease | cystathionine measurement | 2.95e-03 | 19 | 126 | 2 | EFO_0010474 | |
| Disease | bipolar I disorder | 3.19e-03 | 141 | 126 | 4 | EFO_0009963 | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 3.60e-03 | 21 | 126 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Alzheimer disease, age at onset | 3.62e-03 | 343 | 126 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | multiple sclerosis (is_implicated_in) | 3.80e-03 | 73 | 126 | 3 | DOID:2377 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.95e-03 | 74 | 126 | 3 | DOID:3748 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 4.10e-03 | 75 | 126 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.17e-03 | 152 | 126 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | susceptibility to strep throat measurement | 4.26e-03 | 76 | 126 | 3 | EFO_0008408 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPSEDSRGDVRYGQR | 96 | Q4AC99 | |
| DGRPDSGGTLRIYAD | 241 | P55196 | |
| SQEAELSREGPYGRE | 886 | O00555 | |
| DEELVGPLYARSLGA | 26 | P78357 | |
| EGDVLPGLTSRADYA | 211 | Q9Y614 | |
| AREDAGYASLELPGD | 241 | Q8WWN8 | |
| RLGEPNYGAEIRGFS | 1911 | P13611 | |
| EGQGLPLESLRDGSY | 961 | O94812 | |
| RERGRDGAIDLGYDL | 211 | Q13790 | |
| SDRTGLSDYGRRDPE | 566 | Q8IWK6 | |
| LSDYGRRDPEGNLDK | 571 | Q8IWK6 | |
| YGENDLLDLDGDPLR | 431 | O15085 | |
| PGAEDDLALRAALYG | 1101 | Q8IYW2 | |
| DYNGSGRSLLLPFED | 1056 | Q9ULD4 | |
| GASPYRLRRGDGDLE | 206 | Q99767 | |
| EDGEREGSPRTYSRL | 466 | Q8TDJ6 | |
| SGAYGLEQNEPERRE | 476 | Q9BWV3 | |
| ATDRDSGPNGRLLYT | 916 | Q9NYQ6 | |
| SYSDPGLTEDGLGRR | 671 | Q9Y4F5 | |
| TAKGERRREPGGYDS | 161 | Q92997 | |
| GSRIGSDPYLGQRLD | 2251 | Q00975 | |
| GSEYSDRLPLGAEAV | 716 | Q6UXK2 | |
| LPDDDRRGIQQLYGG | 271 | P50281 | |
| FYEGELDDGRRGLVP | 876 | A6NNM3 | |
| FYEGELDDGRRGLVP | 876 | A6NJZ7 | |
| SADDIRGIQSLYGDP | 251 | P39900 | |
| GDSDYDLGRDSPIDR | 881 | Q9HCL0 | |
| LDDRSRYSAGPGREP | 206 | Q8TAE7 | |
| SFGPGEDLLYLRASE | 1801 | O00763 | |
| PARDADAGRLGTQGY | 166 | Q96JQ0 | |
| SDADGPGPNSDVRYR | 1461 | Q96JQ0 | |
| RYGGRVSLTGPLDFE | 2326 | Q96JQ0 | |
| ARREGFPLYEDDEGR | 1036 | Q8TEW8 | |
| SGASRERPGRYPSED | 76 | O60299 | |
| AEIRGGAERGEFPYL | 31 | Q5TCQ9 | |
| GAPEKYESERRLGSE | 566 | P20916 | |
| YEIEDGSTPNGRDLR | 731 | Q16787 | |
| PLESGGREDLTYALR | 346 | P54760 | |
| LGAEDPAVYGDSARE | 41 | Q96EK9 | |
| SLGDTRGFLIDGYPR | 451 | Q9Y6K8 | |
| SNGLPEEDGYSRLSI | 1751 | Q9Y6X6 | |
| YGDELGRERGSPSER | 341 | Q14526 | |
| DGYDNRLRPGLGDSI | 51 | P47869 | |
| RGLAANPGSRYDDLV | 1011 | Q8N6G6 | |
| YRATGDPTLLELGRD | 381 | Q9BV94 | |
| DLGPDGRLLRGYDQS | 126 | P10321 | |
| SERERGGRPYSGVLD | 21 | Q8IYA7 | |
| LREYLYGGGRDEEPS | 56 | Q8NEN9 | |
| GDLLREEYIGDNGDP | 386 | O00748 | |
| ASILDGGDYRPELSI | 111 | O95948 | |
| GDDYREETELGPALS | 351 | P13942 | |
| DEGAGYIADGLRLNR | 266 | Q8N4P6 | |
| EPRDLGGRDDLLYNV | 361 | P54753 | |
| EGAETRGAGDPARYL | 36 | Q9BRS8 | |
| DGYDNRLRPGLGDAV | 76 | P34903 | |
| DGYDNRLRPGLGERV | 51 | P14867 | |
| LLDGYDNRLRPGLGE | 56 | P31644 | |
| RVLLPPDYSEDGARG | 111 | Q8NF86 | |
| PDYSEDGARGDLALL | 116 | Q8NF86 | |
| QRLDYERAAALGGPE | 21 | Q68DK7 | |
| QGTLRGDGTAPREEY | 186 | Q68DD2 | |
| GDGTAPREEYGSRQL | 191 | Q68DD2 | |
| QDGDQAPEYRGRTEL | 86 | Q16653 | |
| LRVYLLPDGREEGAG | 901 | O95248 | |
| LEGDDAPGQSLYERL | 11 | O75344 | |
| RGGRDLDGNGYPDLI | 461 | P08648 | |
| AYDLGGDNERSPRDD | 206 | Q96A11 | |
| LEDPLRGLLSYDEGG | 146 | Q8TES7 | |
| REKGPAARDGTLEYA | 656 | Q92953 | |
| DDRRLGELVVGPYDN | 1126 | Q99715 | |
| PRRSDLDLGYEPEGS | 61 | O15169 | |
| GRPAKLSYTEAEGER | 1136 | O75128 | |
| YQDGPGRGLGEEDIR | 46 | Q96D53 | |
| GAYREVEAEDPGRLA | 181 | Q92839 | |
| PGTFDYQRLDLGGSE | 606 | Q8TEH3 | |
| DPDAGEAGRLVYSLA | 351 | Q9NYQ7 | |
| DLLEGRYFSGALPDD | 31 | P31431 | |
| APDGFYRQDRGLLEG | 441 | Q9Y2W3 | |
| EPDPDYENLRRSAGG | 1326 | P21817 | |
| YGAGEPARLGAREAE | 326 | Q9C009 | |
| DNGSRSGDLPYDGRL | 576 | Q86X29 | |
| SGDLPYDGRLLEEAV | 581 | Q86X29 | |
| LYLENERRSGGGPLE | 191 | Q53GL7 | |
| DLPRGYGETALLRAE | 46 | Q693B1 | |
| GFEPLAYRGLETGSR | 41 | P32754 | |
| RAGYLSDGDSPERPA | 226 | Q6ZW31 | |
| VEYRESRESDLGPAG | 1511 | Q5T011 | |
| DDEDLEPGSYLGRAR | 876 | Q96KN7 | |
| ESAYGRARSDLGAPL | 21 | Q9BWW7 | |
| GDRPLQVGERSDYAG | 41 | A6NHR9 | |
| YLGEEAEGLAAERSP | 581 | Q16650 | |
| LLQAGYDPELRDGDG | 246 | Q9BZL4 | |
| SEEPDGGFRTLYAEL | 676 | Q9BZL4 | |
| YGSSPVEREEGALRR | 841 | Q8N3T6 | |
| GPARGTSDELEDLRY | 866 | Q6ZMZ3 | |
| RTRQGPGAESEDLYD | 401 | Q15345 | |
| FYEGELEDGRRGLVP | 876 | Q9UFD9 | |
| ALPSDAVGYRQEREG | 11 | Q8WUX1 | |
| GYRDDRSPAREPGDV | 111 | P0DPB3 | |
| ASRAEGDDYGQPRSP | 151 | Q9H4M7 | |
| LRGARSYPTLEDEGR | 491 | O60331 | |
| TDPRNYGGDRIILGS | 381 | Q9NTG1 | |
| PYLVFDVGDGSERRD | 2296 | Q7Z333 | |
| LGEYTGRPSDREERE | 191 | P0CK97 | |
| GRTPLDLAAFYGDAE | 1211 | Q9C0D5 | |
| GRTPLDLAAFYGDAE | 1166 | Q9HCD6 | |
| IAPLGDLDRDGYNDI | 391 | P08514 | |
| SLRGAVDIDDNGYPD | 451 | P08514 | |
| SNLPYGDLTEIGERG | 586 | Q96J65 | |
| YRDPPDGSGRLDQLL | 51 | Q96HQ2 | |
| RAGLDLPTIDTGYDS | 196 | O43734 | |
| LYPGDAESLQGALRD | 141 | Q9NS84 | |
| LLAYPRSGEEGDAEQ | 456 | Q9NS84 | |
| SYSDRGEPGAEERAR | 151 | Q9H2X0 | |
| LELARGGGDPYSDLS | 291 | Q8NE01 | |
| PREDGSSGNYRELFL | 771 | P98196 | |
| LGPGGLDDRYSLVSE | 186 | Q9Y446 | |
| VNGRLYELDGLREGP | 171 | Q9Y5K5 | |
| YELDGLREGPIDLGA | 176 | Q9Y5K5 | |
| PYAVARREGLEAAGA | 311 | Q86W33 | |
| YRPSLEGRSDREAPG | 571 | Q9H270 | |
| DGVPVEGSRYAADRR | 161 | P16989 | |
| SSRNDPCRGGGRYEE | 806 | Q8N7X1 | |
| GSGLGSYLLERLNDR | 146 | P23258 | |
| GELEDSGLEEYRPFR | 361 | O15015 | |
| YGEPEERRDVLESSG | 16 | A0A1W2PR48 | |
| ARLGDGARESAPYRG | 56 | O95847 | |
| LGFSTREEGDLGPVY | 121 | P04818 | |
| GPGAEILDLSNDYAR | 276 | Q99551 | |
| EYPGGSRELDRSIRG | 496 | P52849 | |
| LYRELLGGAPGSSEA | 381 | Q92994 | |
| QAGRREGGEAEARPY | 236 | Q5T619 | |
| ALRYGSRDDLVAGPG | 601 | Q9ULC8 | |
| DPDGGLDLEEFSRYL | 61 | Q9BV35 | |
| GSGLGSYLLERLNDR | 146 | Q9NRH3 | |
| ETYGGSDLREDAIAP | 276 | Q96IQ7 | |
| RGEPIRLFGETDYDA | 91 | Q99633 | |
| DYRSGLALPAIDGLD | 1016 | Q04912 | |
| DEDDYSLRGLLPSEG | 81 | Q8N6V9 | |
| YLSLRAGEGRPNGEG | 381 | Q9P2Y4 | |
| LEAYRLGPASAADTG | 96 | Q9NYB0 | |
| GGEEERLSYLGLERD | 211 | Q8N1T3 | |
| EREISGNALRYAPDG | 251 | Q05586 |